M Narazaki
Overview
Explore the profile of M Narazaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1711
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaneko T, Okita Y, Kato Y, Narazaki M, Kumanogoh A
QJM
. 2024 Mar;
117(8):591-592.
PMID: 38539040
No abstract available.
2.
Nakatsubo D, Maeda Y, Hosokawa K, Kawada S, Okamoto M, Shimagami H, et al.
Scand J Rheumatol
. 2022 Aug;
52(1):102-104.
PMID: 35946909
No abstract available.
3.
Morishita M, Sada K, Ohashi K, Miyawaki Y, Asano Y, Hayashi K, et al.
Lupus
. 2020 Jan;
29(2):176-181.
PMID: 31924143
Objective: The objective of this study was to evaluate the chronic damage associated with pregnancies before and after the diagnosis of systemic lupus erythematosus (SLE). Methods: Using childbearing-aged female SLE...
4.
Hishitani Y, Ogata A, Shima Y, Hirano T, Ebina K, Kunugiza Y, et al.
Scand J Rheumatol
. 2013 Mar;
42(4):253-9.
PMID: 23470089
Objectives: The retention of the anti-rheumatic agent tocilizumab (TCZ) has not been well documented in patients with rheumatoid arthritis (RA). We conducted an observational study to compare the retention of...
5.
Nishida S, Hagihara K, Shima Y, Kawai M, Kuwahara Y, Arimitsu J, et al.
Ann Rheum Dis
. 2009 Jun;
68(7):1235-6.
PMID: 19525413
No abstract available.
6.
Kawai M, Hagihara K, Hirano T, Shima Y, Kuwahara Y, Arimitsu J, et al.
Rheumatology (Oxford)
. 2008 Dec;
48(3):318-9.
PMID: 19106169
No abstract available.
7.
Breen E, Gage J, Guo B, Magpantay L, Narazaki M, Kishimoto T, et al.
Cell Immunol
. 2001 Dec;
212(2):118-25.
PMID: 11748928
Cellular responsiveness to human interleukin 6 (hIL6) requires the expression of two receptor molecules: IL6-specific receptor (CD126'IL6R') and a nonspecific signal-transducing molecule (CD130'gp130'). Regulation of responsiveness to hIL6 is generally...
8.
Aoki Y, Narazaki M, Kishimoto T, Tosato G
Blood
. 2001 Nov;
98(10):3042-9.
PMID: 11698289
Receptor usage by viral interleukin-6 (vIL-6), a virokine encoded by Kaposi sarcoma- associated herpesvirus, is an issue of controversy. Recently, the crystal structure of vIL-6 identified vIL-6 sites II and...
9.
Yokota A, Narazaki M, Shima Y, Murata N, Tanaka T, Suemura M, et al.
J Rheumatol
. 2001 Sep;
28(9):1952-9.
PMID: 11550959
Objective: Inflammatory cytokines such as interleukin 1 (IL-1), IL-6, and tumor necrosis factor-alpha are produced in great quantities in inflamed rheumatoid joints. However, little is known about the pathogenic significance...
10.
Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y, Miwa N, et al.
Bioconjug Chem
. 2001 Jul;
12(4):510-4.
PMID: 11459454
Water-soluble gadolinium (Gd) endohedral metallofullerenes have been synthesized as polyhydroxyl forms (Gd@C(82)(OH)(n)(), Gd-fullerenols) and their paramagnetic properties were evaluated by in vivo as well as in vitro for the novel...